JYNT vs TECH · P/E 92, rev $30.2M vs P/E 65, rev $1.22B
The Joint Corp (JYNT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
The Joint Corp (JYNT) is a medical care facilities company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported JYNT revenue for 2024-09-30 was $30.2M. Net income was -$3.2M. Revenue was down 0.2% from 2024-06-30 to 2024-09-30. JYNT currently screens at market cap $117.9M and trailing P/E 91.9.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
JYNT currently screens at market cap $117.9M and trailing P/E 91.9. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the JYNT and TECH stock pages for the full models.
Not investment advice.